Timothy Roe
Contributor since: 2007
Simcere Pharmaceutical Gains on Strong Earnings
China Nepstar Gains on New Century Store Acquisitions
3SBio Plunges on Q4 Earnings Miss
Chindex International Gains on Strong Results
Winter Storms Hit Tongjitang Chinese Medicines
Wuxi Pharmatech Ups Spending, Adds Capacity
In Hospital Advertising Expands in China
Parsing Beijing Med-Pharm Corp.'s Latest Results
Focus Media Builds Yanhuang Health Media Investment
Medtronic Expands Chinese Presence
Earnings Quality Key for China Pharma Investors
Potential IPO Shanghai Bio Boasts Strong Pedigree
Governmental Approval Boosts China-Biotics Shares
Beijing Med-Pharm Signs Shanghai Novartis Deal
China Shenghuo Pharmaceutical Hit on Revenue Decline
3SBio Rises After Hours on Earnings
China Nepstar Jumps on IPO
Chindex International Gains on Strong Earnings
Tongjitang Chinese Medicines Drops Sharply on Earnings, Downgrade
Agria Corporation Slumps on IPO
American Oriental Bioengineering: Underwhelming Q3 Earnings
Simcere Reports Unimpressive Q3 Results
Pfizer Emerges Victorious in China Viagra Patent Battle
Mindray Medical Announces Solid 3Q Results
Alpharma Drops on Shrinking Margins
Benda Pharmaceutical Developing Potential AIDS Vaccine
China Nepstar Files Terms of Upcoming NYSE IPO
Tongjitang Chinese Medicines to Seek FDA Approval for Osteoporosis Treatment
China Osteoporosis Trends Favor Tongjitang Medicines
AIDA Pharmaceuticals Announces Favorable Clinical Trial Findings
Agria Corporation Files for IPO on NYSE
Bruker Biosciences Expands Chinese Presence